Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 299-682-2 | CAS number: 93893-89-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2015-05-27 to 2015-07-29
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5300 - In vitro Mammalian Cell Gene Mutation Test
- Version / remarks:
- 1998
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- 3-methyl-5-phenylpent-2-enenitrile
- EC Number:
- 299-682-2
- EC Name:
- 3-methyl-5-phenylpent-2-enenitrile
- Cas Number:
- 93893-89-1
- Molecular formula:
- C12 H13 N
- IUPAC Name:
- (2E)-3-methyl-5-phenylpent-2-enenitrile
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: MEM (minimal essential medium) containing Hank’s salts supplemented with 10 % foetal bovine serum (FBS), neomycin (5 μg/mL) and amphotericin B (1 %)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: yes - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/β-naphthoflavone induced rat liver S9
- Test concentrations with justification for top dose:
- experiment 1
4 h without metabolic activation: 13.8, 27.5, 55.0, 110.0, 220.0, 330.0, 440.0, 660.0 μg/mL
4 h with metabolic activation: 6.9, 13.8, 27.5, 55.0, 110.0, 165.0, 220.0 μg/mL
experiment 2
24 h without metabolic activation: 13.8, 27.5, 55.0, 110.0, 220.0, 330.0, 440.0 μg/mL
4 h with metabolic activation: 55.0, 110.0, 123.8, 137.5, 151.4, 165.0 μg/mL - Vehicle / solvent:
- - Solvent used: DMSO
- Justification for choice of solvent/vehicle: The solvent was chosen to its solubility properties and its relative non-toxicity to the cell cultures.
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- (EMS) 0.15 mg/mL = 1.2 mM, without metabolic activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- Remarks:
- (DMBA) 1.1 μg/mL = 4.3 μM (experiment I) 2.2 μg/mL = 8.6 μM (experiment II), in DMSO, with metabolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4 and 24 h
- Expression time: 7 days
- Selection time: 8 days
- Fixation time: fixation 7 days after treatment (colonies for cloning efficiency)
SELECTION AGENT: 11 μg/mL 6-thioguanine
STAIN: 10 % methylene blue in 0.01% KOH solution
NUMBER OF REPLICATIONS: 2 experiments with each 2 culture dishes
NUMBER OF CELLS EVALUATED:
The stained colonies with more than 50 cells were counted.
DETERMINATION OF CYTOTOXICITY
- Method: reduction of cloning efficiency
OTHER:
A pre-experiment was performed with and without metabolic activation for the selection of the test substance concentration. Concentrations between 13.8 μg/mL and 1760 μg/mL were tested. It was checked for cytotocix effects, precipitation or phase seperation, pH and osmolarity.
The dose range of experiment 1 were based on the pre-experiment and of experiment 2 on the pre-experiment (without metabolic activation) and experiment 1 (with metabolic activation). - Evaluation criteria:
- Acceptability
The gene mutation assay was considered acceptable if it met the following criteria:
a) the numbers of mutant colonies per 10exp6 cells found in the solvent controls fell within the laboratory historical control data range
b) the positive control substances produced a significant increase in mutant colony frequencies and remained within the historical control range of positive controls
c) the cloning efficiency II (absolute value) of the solvent controls exceeded 50 %.
The study complied with those criteria.
Evaluation
A test item was classified as positive if it induced either a concentration-related increase of the mutant frequency or a reproducible and positive response at one of the test points.
A test item producing neither a concentration-related increase of the mutant frequency nor a reproducible positive response at any of the test points was considered non-mutagenic in this system.
A positive response was described as follows:
A test item was classified as mutagenic if it reproducibly induced a mutation frequency that was three times above the spontaneous mutation frequency at least at one of the concentrations in the experiment.
The test item was classified as mutagenic if there was a reproducible concentration-related increase of the mutation frequency. Such evaluation may be considered also in the case that a threefold increase of the mutant frequency was not observed.
However, in a case by case evaluation this decision depended on the level of the corresponding solvent control data. If there was by chance a low spontaneous mutation rate within the laboratory´s historical control data range, a concentration-related increase of the mutations within this range had to be discussed. The variability of the mutation rates of solvent controls within all experiments of this study was also taken into consideration. - Statistics:
- A linear regression (least squares, calculated using Sum_neu_v2.xltm, version 2.0) was performed to assess a possible dose dependent increase of mutant frequencies. The numbers of mutant colonies generated with the test item were compared to the solvent control groups. A trend was judged as significant whenever the p-value (probability value) was below 0.05. However, both, biological and statistical significance was considered together.
Results and discussion
Test results
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- experiment 1 at 110 μg/mL (without metabolic activation), experiment 2 ≥ 123.8 μg/mL (with metabolic activation)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no effects observed
- Effects of osmolality: no effects observed
- Other confounding effects: In the pre-experiment phase separation was observed at the two highest concentrations of 880.0 and 1760 μg/mL following 4 hours treatment with and without metabolic activation. After 24 hours treatment without metabolic activation phase separation was noted at 1760 μg/mL.
ADDITIONAL INFORMATION ON CYTOTOXICITY: Cytotoxic effects were observed for experiment 1 at 110 μg/mL (without metabolic activation) and for experiment 2 ≥ 123.8 μg/mL (with metabolic activation). The cell cultures at these concentrations were terminated earlier.
Any other information on results incl. tables
concentration [µg/mL] | S9 mix | relative cloning efficiency I [%] | relative cell density [%] | relative cloning efficiency II [%] | mutant colonies/10exp6 cells | induction factor | relative cloning efficiency I [%] | relative cell density [%] | relative cloning efficiency II [%] | mutant colonies/10exp6 cells | induction factor | |
Experiment 1 (4 h treatment) | culture I | culture II | ||||||||||
Solvent control (DMSO) | - | 100 | 100 | 100 | 12.9 | 1 | 100 | 100 | 100 | 16.2 | 1 | |
Positive control (EMS) | 150 | - | 93 | 72.7 | 92.1 | 181.4 | 14.1 | 95.9 | 100.7 | 97.5 | 168.7 | 10.4 |
Test item | 13.8 | - | 99.7 | 131.3 | 92.6 | 23.3 | 1.8 | 105.2 | 130.3 | 101.6 | 9.8 | 0.6 |
27.5 | - | 95 | 109.2 | 90.9 | 14.4 | 1.1 | 98.7 | 86.3 | 100 | 15.1 | 0.9 | |
55 | - | 88.8 | 108.1 | 96.1 | 14 | 1.1 | 90.8 | 131.5 | 99.1 | 12.1 | 0.7 | |
110 | - | 17.6 | 22.1 | 95.5 | 18.2 | 1.4 | 12.8 | 19.8 | 99.6 | 13.6 | 0.8 | |
220 | - | 0 | culture was not continued 1) | 0 | culture was not continued 1) | |||||||
330 | - | 0 | culture was not continued 1) | 0 | culture was not continued 1) | |||||||
440 | - | 0 | culture was not continued 1) | 0 | culture was not continued 1) | |||||||
660 | - | 0 | culture was not continued 1) | 0 | culture was not continued 1) | |||||||
Solvent control (DMSO) | + | 100 | 100 | 100 | 7.6 | 1 | 100 | 100 | 100 | 16.4 | 1 | |
Positive control (DMBA) | 1.1 | + | 102.9 | 85.7 | 103.1 | 221.7 | 29 | 98.7 | 107.9 | 99.9 | 291.5 | 17.8 |
Test item | 3.4 | + | 98.7 | culture was not continued 2) | 102.4 | culture was not continued 2) | ||||||
6.9 | + | 103.1 | 89.4 | 101.7 | 19.5 | 2.6 | 99.8 | 109.2 | 104 | 11.8 | 0.7 | |
13.8 | + | 100.8 | 55.3 | 102.8 | 18 | 2.4 | 103.4 | 125.8 | 103.7 | 14.2 | 0.9 | |
27.5 | + | 98.6 | 66 | 101.6 | 18.8 | 2.5 | 97.4 | 106.5 | 103.3 | 22 | 1.3 | |
55 | + | 93.4 | 72.6 | 102.5 | 17.6 | 2.3 | 91.5 | 111.7 | 104.7 | 13 | 0.8 | |
110 | + | 53.8 | 49.8 | 102.9 | 20.1 | 2.6 | 60.5 | 72.6 | 103.4 | 31.1 | 1.9 | |
165 | + | 0 | culture was not continued 1) | 0 | culture was not continued 1) | |||||||
220 | + | 0 | culture was not continued 1) | 0 | culture was not continued 1) | |||||||
Experiment 2 (24 h treatment) | culture I | culture II | ||||||||||
Solvent control (DMSO) | - | 100 | 100 | 100 | 14 | 1 | 100 | 100 | 100 | 9.6 | 1 | |
Positive control (EMS) | 150 | - | 93.1 | 80.3 | 69.8 | 370.1 | 26.4 | 72 | 79.5 | 99.2 | 350.9 | 36.6 |
Test item | 6.9 | - | culture was not continued 2) | culture was not continued 2) | ||||||||
13.8 | - | 99.4 | 110 | 76.3 | 18.9 | 1.3 | 97.5 | 111.5 | 95.7 | 21.9 | 2.3 | |
27.5 | - | 93.4 | 92.6 | 90.5 | 11.9 | 0.9 | 95.1 | 96.3 | 101.3 | 9.9 | 1 | |
55 | - | 94.5 | 80.5 | 83.5 | 17.1 | 1.2 | 84.4 | 82.1 | 99.4 | 28.6 | 3 | |
110 | - | 96.1 | 76.7 | 73.2 | 23.1 | 1.6 | 70.8 | 70.1 | 99.1 | 10.4 | 1.1 | |
220 | - | 0 | 8.4 | culture was not continued 1) | 0 | 8.8 | culture was not continued 1) | |||||
330 | - | 0 | 0 | culture was not continued 1) | 0 | 3.9 | culture was not continued 1) | |||||
440 | - | culture was not continued 1) | culture was not continued 1) | |||||||||
Experiment 2 (4 h treatment) | culture I | culture II | ||||||||||
Solvent control (DMSO) | + | 100 | 100 | 100 | 24.5 | 1 | 100 | 100 | 100 | 11 | 1 | |
Positive control (DMBA) | 2.2 | + | 79.9 | 85.7 | 104.2 | 236.3 | 9.6 | 98.3 | 97.2 | 78.8 | 258.8 | 23.6 |
Test item | 13.8 | + | culture was not continued 2) | culture was not continued 2) | ||||||||
27.5 | + | 84.9 | culture was not continued 2) | 88.6 | culture was not continued 2) | |||||||
55 | + | 80.2 | 81.2 | 102.3 | 25 | 1 | 86.9 | 135.8 | 92.5 | 7.2 | 0.7 | |
110 | + | 55.6 | 101.7 | 101.5 | 21.4 | 0.9 | 63.2 | 114.5 | 84.8 | 13.5 | 1.2 | |
123.8 | + | 19.6 | 93.6 | 100.9 | 25.9 | 1.1 | 29 | 78.2 | 93.9 | 18.9 | 1.7 | |
137.5 | + | 7.4 | 85.8 | 99.1 | 26.7 | 1.1 | 6.1 | 59.4 | 77.8 | 24.1 | 2.2 | |
151.4 | + | 5.3 | 59.3 | 101.6 | 25.8 | 1.1 | 3.8 | 54 | 76.2 | 32.3 | 2.9 | |
165 | + | culture was not continued 2) | 0 | culture was not continued 2) |
1) culture was not continued due to exceedingly severe cytotoxic effects
2) culture was not continued since a minimum of only four analysable concentrations is required
Applicant's summary and conclusion
- Conclusions:
- An in vitro gene mutation study (HPRT) was conducted in V79 cells of the Chinese hamster. It was concluded that the test substance did not induce gene mutations at the HPRT locus and therefore was considered to be non-mutagenic.
- Executive summary:
An in vitro gene mutation study (HPRT) according to OECD Guideline 476 was conducted in V79 cells of the Chinese hamster. A pre-experiment was performed with and without metabolic activation for the selection of the test substance concentration. Concentrations between 13.8 μg/mL and 1760 μg/mL were tested. For the main experiments a concentration range between 6.9 and 660 μg/mL was used. The main assay was performed in two independent experiments. The cells were exposed to the test item for 4 hours in the first experiment with and without metabolic activation. The second experiment was performed with a treatment time of 4 hours with and 24 hours without metabolic activation. The used concentration range of the experiments was limited by cytotoxic effects. Cytotoxic effects were observed for experiment 1 at 110 μg/mL (without metabolic activation) and for experiment 2 ≥ 123.8 μg/mL (with metabolic activation). No substantial and reproducible dose dependent increase of the mutation frequency was observed in both main experiments. It was concluded that the test substance did not induce gene mutations at the HPRT locus and therefore was considered to be non-mutagenic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
